Generated by GPT-5-mini| Centre for Cellular and Molecular Platforms | |
|---|---|
| Name | Centre for Cellular and Molecular Platforms |
| Founded | 2009 |
| Headquarters | Bangalore, India |
| Type | Research infrastructure |
| Services | Core facilities, instrumentation, training |
Centre for Cellular and Molecular Platforms is an Indian research infrastructure organization providing shared access to advanced microscopy platforms, genomics technologies, and bioinformatics services. It operates as a translational enabling center linking academic Indian Institute of Science, industrial partners such as Biocon and Dr. Reddy's Laboratories, and international initiatives like the Human Cell Atlas and Horizon 2020. The center supports projects spanning from basic cell biology to applied biotechnology and collaborates with government agencies including Department of Biotechnology (India) and Council of Scientific and Industrial Research.
Founded in 2009 with support from the Department of Biotechnology (India) and seed partners including National Centre for Biological Sciences and Indian Institute of Science, the organization built core infrastructure to address capacity gaps identified by networks such as the International Society for Advancement of Cytometry and the Global Alliance for Genomics and Health. Early milestones involved acquisition of instrumentation from vendors associated with Thermo Fisher Scientific and Illumina and pilot service agreements with institutions like All India Institute of Medical Sciences and Tata Institute of Fundamental Research. Subsequent expansions aligned with national initiatives exemplified by Make in India and international collaborations under programs like Newton Fund and Global Challenges Research Fund.
The center operates multi-user facilities that include high-end confocal and super-resolution platforms comparable to those at EMBL and Wellcome Sanger Institute, flow cytometry suites paralleling capabilities at NIH, and sequencing cores offering short-read and long-read technologies used by Broad Institute affiliates. Services extend to clinical-grade sample processing standards recognized by Clinical Laboratory Improvement Amendments-type frameworks and to bioinformatics pipelines influenced by practices at European Bioinformatics Institute and NCBI. Additional offerings include antibody validation platforms used in research at Cold Spring Harbor Laboratory, proteomics workstreams reflecting standards from Max Planck Institute for Biochemistry, and biophysical instrumentation similar to resources at Lawrence Berkeley National Laboratory.
Research partnerships span academic centers such as Indian Institute of Science Education and Research, Pune, Jawaharlal Nehru Centre for Advanced Scientific Research, and translational collaborators including Serum Institute of India and Cipla. International collaborations have linked projects with Wellcome Trust, Bill & Melinda Gates Foundation, and networks like the Human Cell Atlas and Global Virome Project. Collaborative research themes include single-cell transcriptomics inspired by methods developed at Broad Institute, pathogen genomics related to work at Institute of Virology, Wuhan, and cellular therapeutics echoing programs at Karolinska Institutet and Massachusetts General Hospital.
The center runs training courses modeled after workshops at Cold Spring Harbor Laboratory and EMBO practical courses, offering hands-on modules in microscopy, flow cytometry, and next-generation sequencing used by staff from All India Institute of Medical Sciences, Christian Medical College, Vellore, and King Edward Memorial Hospital. Outreach includes summer schools that mirror programs at European Molecular Biology Laboratory and public engagement events co-organized with India Alliance and National Academy of Sciences, India. The center’s capacity-building efforts draw visiting faculty from institutions such as Stanford University, University of Cambridge, and Harvard Medical School.
Governance involves a board comprising representatives from funding agencies like Department of Biotechnology (India), academic partners such as Indian Institute of Science, and industry stakeholders similar to those engaged by Biocon. Funding streams combine government grants, philanthropic awards from entities like Bill & Melinda Gates Foundation, fee-for-service income comparable to cost-recovery models at Wellcome Sanger Institute, and project-specific support through mechanisms akin to Horizon 2020 consortia. Strategic oversight aligns with national research priorities endorsed by bodies including Prime Minister's Office (India)-backed initiatives and advisory inputs from networks like National Institute of Immunology.
Notable projects include contributions to SARS-CoV-2 sequencing efforts parallel to national efforts led by Indian SARS-CoV-2 Genomics Consortium and participation in single-cell atlasing projects reminiscent of the Human Cell Atlas. The center has enabled translational studies with partners such as Tata Memorial Centre on cancer genomics and clinical immunology initiatives with Christian Medical College, Vellore. Technology deployments supported start-ups in the biotechnology ecosystem similar to companies incubated at Biocon Biologics and accelerators like Startup Village. Outputs include peer-reviewed collaborations with groups at University of Oxford, Imperial College London, and University of California, San Francisco, and capacity building reflected in alumni joining institutions such as National Institutes of Health and Max Planck Society.
Category:Research institutes in India Category:Biotechnology organizations